Company Sponsored Research: Sidoti & Company, LLC
PpHYzvsV_400x400.jpg

Myomo

Equity research on Myomo (MYO) produced by Sidoti as part of its Company Sponsored Research program.

 IXYS


DOWNLOAD RESEARCH BELOW

Analyst: Jim Sidoti

Myomo, Inc.

(NYSE American: MYO)

Myomo, Inc., a commercial stage medical robotics company, designs, develops, and produces myoelectric braces or orthotics for people suffering with neuromuscular disorders in the United States. It offers MyoPro, a powered upper limb orthosis that supports the arm, as well as restores function to the weakened or paralyzed arms of patients suffering from CVA stroke, brachial plexus injury, traumatic brain injury, spinal cord injury, ALS, or other neuromuscular disease or injury. The company serves orthotics and prosthetics practices or clinics, as well as the veteran administration and other hospitals through orthotics and prosthetics providers, and distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Cambridge, Massachusetts.

 

 

 Initiation Report: June 20, 2018

Initiation Report: June 20, 2018

 Earnings Release: August 8, 2018

Earnings Release: August 8, 2018

 Update Report:  September 19, 2018

Update Report: September 19, 2018